Search results
“House of the Dragon”'s Tom Glynn-Carney on Aegon's fate: 'It is really intense'
Entertainment Weekly via Yahoo News· 9 hours agoThings seem to be working out in the one-eyed dragon rider's favor, while questions still persist as...
Clarence Thomas, a $267,000 RV, and Why American Health Care Sucks
Rolling Stone via Yahoo News· 2 days agoBut they also called on Congress and the court to revisit “what is an unjust and increasingly ...
The Spiritual Price of Fly Me to the Moon's Conspiracy Romp
Time via Yahoo News· 3 days agoWhen the cables tangle and the astronauts wind up suspended in mid-air, the (real) movie earns an...
These are the worst areas in England for your hair and skin
Yahoo Life UK· 3 days ago"For hair, this can mean dryness, dullness, and more tangles because the minerals form a film that...
Opinion: Fighting antisemitism, one curl at a time
CNN via Yahoo News· 4 days agoAfter years spent stressing over her curly hair, Jackie Delamatre writes that her natural hair is an expression of her Jewish identity and a form of...
Opinion: Even the toughest fighters eventually lose the battle with time. Biden is no exception
LA Times via Yahoo News· 4 days agoWatching the 81-year-old president, I realize he's waging the same battle my sister fought for...
Cricket-England close on big win in Anderson farewell
Reuters via Yahoo News· 4 days agoLONDON (Reuters) -West Indies limped to 79-6 at the close on the second day of the first test...
Using Exposure Management to strengthen organizational defenses
TechRadar via Yahoo News· 4 days agoThis can become a serious security risk, especially if these older assets remain connected to the...
Artificial Intelligence and Its Pitfalls Are at the Core of Bucheon Film Festival Revamp:...
Variety via Yahoo News· 4 days agoAt a conference on film and artificial intelligence over the weekend in South Korea’s Bucheon, it...
Athira (ATHA) Completes Dosing in Alzheimer's Study, Stock Up
Zacks via Yahoo News· 5 days agoAthira (ATHA) completes dosing the last patient in the phase II/III LIFT-AD study on fosgonimeton...